Mdxhealth SA (MDXH) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Mdxhealth SA (MDXH) following the 2026 Q2 hedge fund 13F filings?

As of today, MDXH has moved -27.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +1.7% for the XLV sector ETF — an outperformance of -28.7%. Since the quarter end (June 30, 2026), MDXH gained +43.7% vs +7.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Mdxhealth SA (MDXH)

26 + Investors. Track Smart Money conviction in MDXH. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MDXH

Based on 26 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds reduced or closed their MDXH positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

🔻

Below peak — only 46% of 3.0Y high

46% of all-time peak

Only 26 funds hold MDXH today versus a peak of 56 funds at 2025 Q4 — just 46% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.

🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q

+5 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🔴

Heavy selling pressure — only 26% buying

12 buying35 selling

Last quarter: 35 funds sold vs only 12 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

➡️

Steady new buyers — ~5 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 23 → 19 → 9 → 5. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

📌

Mixed — 27% long-term, 38% new

■ 27% conviction (2yr+) ■ 35% medium ■ 38% new

Of the 26 current holders: 7 (27%) held >2 years, 9 held 1–2 years, and 10 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

⚠️

Saturation — most institutions already know this story

3 → 23 → 19 → 9 → 5 new funds/Q

New funds entering each quarter: 23 → 19 → 9 → 5. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.

🏛️

Veteran-anchored — 42% veterans vs 46% newcomers

■ 42% veterans ■ 12% 1-2yr ■ 46% new

Entry-cohort mix of 26 holders: 11 (42%) are 2+ year veterans, 3 entered 1–2 years ago, and 12 (46%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds

7 of 26 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

2.5

out of 10

Low Exit Risk

Exit risk score 2.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	26	51	-49.02%
13F Shares	17M	149M	-88.87%
Total Value	$7M	$343M	-98.09%
New Positions	5	9	-4
Increased Positions	7	12	-5
Closed Positions	30	14	+16
Reduced Positions	5	17	-12
Total Calls	0	1	-100.0%
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-49.02%

13F Shares

17M

149M

-88.87%

Total Value

$7M

$343M

-98.09%

New Positions

-4

Increased Positions

-5

Closed Positions

+16

Reduced Positions

-12

Total Calls

-100.0%

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

26 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MDXH. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 23 MDXH holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	MVM Partners, LLC	100.00%	4,700,457	$1.9M
2	Bleichroeder LP	0.54%	7,378,333	$3.0M
3	Perkins Capital Management Inc	0.44%	1,411,891	$580K
4	Ground Swell Capital, LLC	0.04%	88,114	$36K
5	XTX Topco Ltd	0.00%	195,039	$80K
6	Intesa Sanpaolo Wealth Management	0.00%	10,000	$4K
7	FAS Wealth Partners, Inc.	0.00%	22,625	$9K
8	Tower Research Capital LLC (TRC)	0.00%	36,549	$15K
9	Renaissance Technologies LLC	0.00%	325,084	$133K
10	Hrt Financial LP	0.00%	184,477	$75K
11	Squarepoint Ops LLC	0.00%	200,281	$82K
12	Millennium Management LLC	0.00%	228,510	$94K
13	Monetary Solutions, Ltd	0.00%	85	—
14	Citadel Advisors LLC	0.00%	509,674	$209K
15	Lido Advisors, LLC	0.00%	20,253	$8K
16	Jane Street Group, LLC	0.00%	503,219	$207K
17	BlackRock, Inc.	0.00%	147,063	$60K
18	SBI Securities Co., Ltd.	0.00%	29	—
19	Farther Finance Advisors, LLC	0.00%	10	—
20	Morgan Stanley	0.00%	764	—
21	Wells Fargo & Company/Mn	0.00%	200	—
22	Barclays plc	0.00%	16	—
23	UBS Group AG	0.00%	3	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Mdxhealth SA (MDXH)

What does the Smart Money Trend signal show for MDXH?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their MDXH positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for MDXH?

Heavy selling pressure — only 26% buying: Last quarter: 35 funds sold vs only 12 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for MDXH holders?

Smaller funds dominant — 6% AUM from top-100: 7 of 26 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held MDXH?

Mixed — 27% long-term, 38% new: Of the 26 current holders: 7 (27%) held >2 years, 9 held 1–2 years, and 10 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Mdxhealth SA (MDXH) following the 2026 Q2 hedge fund 13F filings?

As of today, MDXH has moved -27.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +1.7% for the XLV sector ETF — an outperformance of -28.7%. Since the quarter end (June 30, 2026), MDXH has gained +43.7% vs +7.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Mdxhealth SA (MDXH)

Smart Money Signals — MDXH

Selling streak — 2 quarters in a row

Below peak — only 46% of 3.0Y high

Fast accumulation — +24% more funds vs a year ago

Heavy selling pressure — only 26% buying

Steady new buyers — ~5 new funds per quarter

Mixed — 27% long-term, 38% new

Saturation — most institutions already know this story

Veteran-anchored — 42% veterans vs 46% newcomers

Smaller funds dominant — 6% AUM from top-100

Institutional Sentiment Summary — MDXH

Hedge Fund Ownership: MDXH

Market Analysis: MDXH

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MDXH

Is It Too Late to Buy Mdxhealth SA (MDXH) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: MDXH

Statistics: MDXH

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Mdxhealth SA (MDXH)

Welcome to 13Foresight!